Why Is Longeveron ( $LGVN ) Stock Down -55.99% Today? (Find out why any stock moved today on Tickeron.) Shares plunged roughly 56%, tumbling from a prior close of $6.68 to about $2.94 in intraday trading. Primary catalyst: The company's ELPIS II Phase 2b trial of laromestrocel failed to meet its primary efficacy endpoint in infants with hypoplastic left heart syndrome (HLHS). $QURE $BIVI $SNGX $MGNX $INKT
published
Why Is Longeveron ( $LGVN ) Stock Down -55.99% Today? (Find out why any stock moved today on Tickeron.) Shares plunged roughly 56%, tumbling from a prior close of $6.68 to about $2.94 in intraday trading. Primary catalyst: The company's ELPIS II Phase 2b trial
$LGVN$QURE$BIVI$SNGX$MGNX$INKT
Latest documented BWB result
See Billy's timestamped results and follow-through.
Review the latest gains posts, original timestamps, and proof images published by Banking With Billy.
Historical results are not a promise of future performance. Trading involves substantial risk.This public post is a timestamped information archive, not personalized financial advice. Alerts can change as markets move. Join Billy's private group for the complete daily stream and follow-through.